These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26112898)

  • 1. Imaging-based screening: maximizing benefits and minimizing harms.
    Germino JC; Elmore JG; Carlos RC; Lee CI
    Clin Imaging; 2016; 40(2):339-43. PubMed ID: 26112898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging-based screening: understanding the controversies.
    Lam DL; Pandharipande PV; Lee JM; Lehman CD; Lee CI
    AJR Am J Roentgenol; 2014 Nov; 203(5):952-6. PubMed ID: 25341132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Lung Cancer Screening Program Websites.
    Clark SD; Reuland DS; Enyioha C; Jonas DE
    JAMA Intern Med; 2020 Jun; 180(6):824-830. PubMed ID: 32282024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of harms in cancer screening trials: literature review.
    Heleno B; Thomsen MF; Rodrigues DS; Jørgensen KJ; Brodersen J
    BMJ; 2013 Sep; 347():f5334. PubMed ID: 24041703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to prevent overdiagnosis.
    Chiolero A; Paccaud F; Aujesky D; Santschi V; Rodondi N
    Swiss Med Wkly; 2015; 145():w14060. PubMed ID: 25612105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?
    Rahbar H; McDonald ES; Lee JM; Partridge SC; Lee CI
    Acad Radiol; 2016 Jun; 23(6):768-73. PubMed ID: 27017136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
    Onega T; Beaber EF; Sprague BL; Barlow WE; Haas JS; Tosteson AN; D Schnall M; Armstrong K; Schapira MM; Geller B; Weaver DL; Conant EF
    Cancer; 2014 Oct; 120(19):2955-64. PubMed ID: 24830599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overdiagnosis of thyroid cancer: answers to five key questions.
    Hoang JK; Nguyen XV; Davies L
    Acad Radiol; 2015 Aug; 22(8):1024-9. PubMed ID: 26100186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
    Gocko X; Leclerq M; Plotton C
    Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving paradigms in breast cancer screening: Balancing efficacy, personalization, and equity.
    Pesapane F; Rotili A; Raimondi S; Aurilio G; Lazzeroni M; Nicosia L; Latronico A; Pizzamiglio M; Cassano E; Gandini S
    Eur J Radiol; 2024 Mar; 172():111321. PubMed ID: 38244317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?--no.
    Bell RJ; Burton RC
    Med J Aust; 2012 Jan; 196(1):17. PubMed ID: 22256918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.
    Gulati R; Gore JL; Etzioni R
    Ann Intern Med; 2013 Feb; 158(3):145-53. PubMed ID: 23381039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missteps in Current Estimates of Cancer Overdiagnosis.
    Lee CI; Etzioni R
    Acad Radiol; 2017 Feb; 24(2):226-229. PubMed ID: 27894707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in diagnostic error rates of 10 MRI centers performing lumbar spine MRI examinations on the same patient within a 3-week period.
    Herzog R; Elgort DR; Flanders AE; Moley PJ
    Spine J; 2017 Apr; 17(4):554-561. PubMed ID: 27867079
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.